keyword
MENU ▼
Read by QxMD icon Read
search

Active surveillance prostate

keyword
https://www.readbyqxmd.com/read/28090626/active-surveillance-of-prostate-cancer
#1
Peter L Choyke, Stacy Loeb
No abstract text is available yet for this article.
January 15, 2017: Oncology (Williston Park, NY)
https://www.readbyqxmd.com/read/28089304/management-of-prostate-cancer-in-elderly-patients-recommendations-of-a-task-force-of-the-international-society-of-geriatric-oncology
#2
REVIEW
Jean-Pierre Droz, Gilles Albrand, Silke Gillessen, Simon Hughes, Nicolas Mottet, Stéphane Oudard, Heather Payne, Martine Puts, Gilbert Zulian, Lodovico Balducci, Matti Aapro
CONTEXT: Prostate cancer is the most frequent male cancer. Since the median age of diagnosis is 66 yr, many patients require both geriatric and urologic evaluation if treatment is to be tailored to individual circumstances including comorbidities and frailty. OBJECTIVE: To update the 2014 International Society of Geriatric Oncology (SIOG) guidelines on prostate cancer in men aged >70 yr. The update includes new material on health status evaluation and the treatment of localised, advanced, and castrate-resistant disease...
January 11, 2017: European Urology
https://www.readbyqxmd.com/read/28086943/a-lifestyle-intervention-among-elderly-men-on-active-surveillance-for-non-aggressive-prostate-cancer-a-randomised-feasibility-study-with-whole-grain-rye-and-exercise
#3
Anne Kirstine Eriksen, Rikke Dalgaard Hansen, Michael Borre, Ryan Godsk Larsen, Jeppe Munthe Jensen, Kristian Overgaard, Mette Borre, Cecilie Kyrø, Rikard Landberg, Anja Olsen, Anne Tjønneland
BACKGROUND: The prognosis for men with non-aggressive prostate cancer is good, and several studies have investigated the impact of lifestyle changes including physical activity and diet on the prognosis. Despite positive results in animal studies and a few human interventions with whole-grain rye on markers of prostate cancer progression, the feasibility of trials investigating such dietary changes in combination with physical activity remains largely unstudied. The primary aim was to investigate the feasibility of an intervention with high whole-grain rye intake and vigorous physical activity for 6 months in men diagnosed with prostate cancer...
January 13, 2017: Trials
https://www.readbyqxmd.com/read/28075651/imaging-characteristics-of-prostate-cancer-patients-who-discontinued-active-surveillance-on-3-t-multiparametric-prostate-mri
#4
David J Habibian, Corinne C Liu, Alex Dao, Kaitlin E Kosinski, Aaron E Katz
OBJECTIVE: Early-stage prostate cancer may be followed with active surveillance to avoid overtreatment. Our institution's active surveillance regimen uses annual MRI in place of serial biopsies, and biopsies are performed only when clinically necessary. The objective of our study was to report the multiparametric MRI characteristics of prostate cancer patients who discontinued active surveillance at our institution after repeat imaging revealed possible evidence of tumor upgrading. MATERIALS AND METHODS: The Department of Urology at Winthrop University Hospital prospectively maintains a database of prostate cancer patients who are monitored with active surveillance...
January 11, 2017: AJR. American Journal of Roentgenology
https://www.readbyqxmd.com/read/28073197/detection-rate-for-significant-cancer-at-confirmatory-biopsy-in-men-enrolled-in-active-surveillance-protocol-20-cores-vs-30-cores-vs-mri-trus-fusion-prostate-biopsy
#5
Pietro Pepe, Sebastiano Cimino, Antonio Garufi, Giandomenico Priolo, Giorgio Ivan Russo, Raimondo Giardina, Giulio Reale, Michele Barbera, Paolo Panella, Michele Pennisi, Giuseppe Morgia
INTRODUCTION: The detection rate for significant prostate cancer of extended vs saturation vs mMRI/TRUS fusion biopsy was prospectively evaluated in men enrolled in active surveillance (AS) protocol. Mterials and methods: From May 2013 to September 2016 75 men aged 66 years (median) with very low risk PCa were enrolled in an AS protocol and elegible criteria were: life expectancy greater than 10 years, cT1C, PSA below 10 ng/ml, PSA density < 0.20, 2 < unilateral positive biopsy cores, Gleason score (GS) equal to 6, greatest percentage of cancer (GPC) in a core < 50%...
December 30, 2016: Archivio Italiano di Urologia, Andrologia
https://www.readbyqxmd.com/read/28073195/cognitive-zonal-fusion-biopsy-of-the-prostate-original-technique-between-target-and-saturation
#6
Andrea B Galosi, Guevar Maselli, Giulia Sbrollini, Gaetano Donatelli, Lorenzo Montesi, Matteo Tallè, Rodolfo Montironi
: We describe our experience in prostate biopsy using a new standardized cognitive fusion techniques, that we call "cognitive zonal fusion biopsy". This new technique is based on two operative options: the first based on target biopsies, the Cognitive Target Biopsy (CTB) if the same target was detected with transrectal ultrasound (TRUS) and multiparametric magnetic resonance (mpMRI); the second based on saturation biopsies, the Zonal Saturation Biopsy (ZSB) on anatomical zone/s containing the region of interest if the same target was not evident with TRUS and MRI...
December 30, 2016: Archivio Italiano di Urologia, Andrologia
https://www.readbyqxmd.com/read/28034917/active-surveillance-for-low-risk-localized-prostate-cancer-what-do-men-and-their-partners-think
#7
Arun Mallapareddi, Julie Ruterbusch, Elyse Reamer, Susan Eggly, Jinping Xu
BACKGROUND: Active surveillance (AS) is recognized as a reasonable treatment option for low-risk localized prostate cancer (LPC) but continues to be chosen by a minority of men. To date, limited data are available regarding reasons why men with low-risk LPC adopt AS. PURPOSE: The aim of this study is to better understand conceptualizations, experiences and reasons why men with low-risk LPC and their partners adopt AS. METHODS: We conducted five focus groups (FGs), three among men with low-risk LPC who had chosen AS and two with their partners...
December 29, 2016: Family Practice
https://www.readbyqxmd.com/read/28031932/biomarkers-for-prostate-cancer-present-challenges-and-future-opportunities
#8
REVIEW
Pranav Sharma, Kamran Zargar-Shoshtari, Julio M Pow-Sang
Prostate cancer (PCa) has variable biological potential with multiple treatment options. A more personalized approach, therefore, is needed to better define men at higher risk of developing PCa, discriminate indolent from aggressive disease and improve risk stratification after treatment by predicting the likelihood of progression. This may improve clinical decision-making regarding management, improve selection for active surveillance protocols and minimize morbidity from treatment. Discovery of new biomarkers associated with prostate carcinogenesis present an opportunity to provide patients with novel genetic signatures to better understand their risk of developing PCa and help forecast their clinical course...
March 2016: Future Science OA
https://www.readbyqxmd.com/read/28031426/molecular-profiling-to-determine-clonality-of-serial-magnetic-resonance-imaging-ultrasound-fusion-biopsies-from-men-on-active-surveillance-for-low-risk-prostate-cancer
#9
Ganesh S Palapattu, Simpa S Salami, Andi K Cani, Daniel H Hovelson, Lorena Lazo de la Vega, Kelly R Vandenberg, Jarred V Bratley, Chia-Jen Liu, Lakshmi P Kunju, Jeffery S Montgomery, Todd M Morgan, Shyam Natarajan, Jiaoti Huang, Scott A Tomlins, Leonard S Marks
PURPOSE: To determine whether MRI/ultrasound (MRI/US) fusion biopsy facilitates longitudinal resampling of the same clonal focus of prostate cancer and to determine whether high-grade cancers can evolve from low-grade clones. EXPERIMENTAL DESIGN: All men on active surveillance who underwent tracking MRI/US fusion biopsy of Gleason 6 prostate cancer, on at least two distinct occasions, between 2012 and 2014 were enrolled. MRI/US fusion was used to track and resample specific cancer foci...
October 7, 2016: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
https://www.readbyqxmd.com/read/28007457/padeliporfin-vascular-targeted-photodynamic-therapy-versus-active-surveillance-in-men-with-low-risk-prostate-cancer-clin1001-pcm301-an-open-label-phase-3-randomised-controlled-trial
#10
Abdel-Rahmène Azzouzi, Sébastien Vincendeau, Eric Barret, Antony Cicco, François Kleinclauss, Henk G van der Poel, Christian G Stief, Jens Rassweiler, Georg Salomon, Eduardo Solsona, Antonio Alcaraz, Teuvo T Tammela, Derek J Rosario, Francisco Gomez-Veiga, Göran Ahlgren, Fawzi Benzaghou, Bertrand Gaillac, Billy Amzal, Frans M J Debruyne, Gaëlle Fromont, Christian Gratzke, Mark Emberton
BACKGROUND: Vascular-targeted photodynamic therapy, a novel tissue-preserving treatment for low-risk prostate cancer, has shown favourable safety and efficacy results in single-arm phase 1 and 2 studies. We compared this treatment with the standard of care, active surveillance, in men with low-risk prostate cancer in a phase 3 trial. METHODS: This randomised controlled trial was done in 47 European university centres and community hospitals. Men with low-risk, localised prostate cancer (Gleason pattern 3) who had received no previous treatment were randomly assigned (1:1) to vascular-targeted photodynamic therapy (4 mg/kg padeliporfin intravenously over 10 min and optical fibres inserted into the prostate to cover the desired treatment zone and subsequent activation by laser light 753 nm with a fixed power of 150 mW/cm for 22 min 15 s) or active surveillance...
December 19, 2016: Lancet Oncology
https://www.readbyqxmd.com/read/28004265/active-surveillance-for-low-risk-prostate-cancer-in-austria-the-online-registry-of-the-qualit%C3%A3-tspartnerschaft-urologie-quapu
#11
Klaus Eredics, Karl Dorfinger, Gero Kramer, Anton Ponholzer, Stephan Madersbacher
BACKGROUND: Active surveillance (AS) is a well-recognized strategy to reduce the risk of overtreatment in men with low-risk prostate cancer. No data on this approach are available from Austria. METHODS: The Qualitätspartnerschaft Urologie (QuapU) developed an online database for patients managed with AS in Austria. Principal inclusion/exclusion criteria corresponded to those of the S3 prostate cancer guideline of German urologists: prostate-specific antigen (PSA) <10 ng/ml, Gleason score <7 (maximum 20% of biopsies being positive)...
December 21, 2016: Wiener Klinische Wochenschrift
https://www.readbyqxmd.com/read/27998677/clinically-localized-prostate-cancer-in-2017-a-review-of-comparative-effectiveness
#12
REVIEW
Hugh J Lavery, Matthew R Cooperberg
Introducing the topic of comparative effectiveness for prostate cancer treatments with a reminder of the disease's heterogeneity risks tautology. However, the profound variation both in this cancer's biology and its clinical course is increasingly widely recognized, while management alternatives for clinically localized prostate cancer have exploded. Available options now include active surveillance, multiple surgical approaches to prostatectomy, various forms of external-beam and interstitial radiation, and a growing list of energy ablative technologies...
December 17, 2016: Urologic Oncology
https://www.readbyqxmd.com/read/27998229/active-surveillance-of-localized-prostate-cancer-acknowledging-uncertainty
#13
Jeffrey J Tosoian, H Ballentine Carter
No abstract text is available yet for this article.
December 20, 2016: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/27993665/active-surveillance-for-favorable-risk-prostate-cancer-in-african-caribbean-men-results-of-a-prospective-study
#14
Matthias Meunier, Rémi Eyraud, Cédric Sénéchal, Gilles Gourtaud, Virginie Roux, Cécilia Lanchon, Laurent Brureau, Pascal Blanchet
PURPOSE: Active surveillance (AS) is a treatment option for favorable-risk prostate cancers (PCa). However, data concerning populations of African descent is missing. We evaluated the safety and benefit of AS in an African Caribbean cohort with favorable-risk PCa. MATERIAL AND METHODS: Between 2005 and 2016, a monocentric prospective cohort study was conducted in Guadeloupe (French West Indies), including patients with low-risk PCa (prostate-specific antigen [PSA] ≤10 ng/ml; Gleason ≤6) or favorable intermediate-risk PCa (PSA, 10-20 ng/ml; Gleason ≤3+4; life expectancy <10 years) in AS...
December 16, 2016: Journal of Urology
https://www.readbyqxmd.com/read/27986459/-oncological-results-of-active-surveillance-in-prostate-cancer-a-retrospective-multicentric-cohort
#15
P Mortier, C Bastide, E Lechevallier, J Walz, R Fournier, P-H Savoie, K Ben Othman, R Giorgi, M André, S Giusiano, D Rossi
PURPOSE: To report oncological outcomes of patients with prostate cancer undergoing active surveillance according to SURACAP criteria. METHODS: This multicentric study included patients who were initially treated with active surveillance for localized prostate cancer according to the SURACAP criteria. The duration of active surveillance as well as the causes of discontinuing the protocol and the definitive pathological results of patients who further underwent radical prostatectomy were retrospectively evaluated...
December 13, 2016: Progrès en Urologie
https://www.readbyqxmd.com/read/27984110/more-judicious-use-of-expectant-management-for-localized-prostate-cancer-over-the-past-two-decades
#16
J B Eifler, J Alvarez, T Koyama, R M Conwill, C R Ritch, K E Hoffman, M J Resnick, D F Penson, D A Barocas
INTRODUCTION: Urologists have been criticized for over-treating men with low-risk prostate cancer, and for passively observing older men with higher-risk disease. Proponents of active surveillance (AS) for low-risk disease and critics of watchful waiting (WW) for higher-risk disease have advocated for more judicious use of observation. Thus, we compared two population-based cohorts to determine how expectant management has evolved over the past two decades. METHODS: 5,871 men with localized prostate cancer were enrolled in the Prostate Cancer Outcomes Study (PCOS: 1994 to 1995) or the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR: 2011 to 2012) study...
October 27, 2016: Journal of Urology
https://www.readbyqxmd.com/read/27979510/re-treatment-preferences-for-active-surveillance-versus-active-treatment-among-men-with-low-risk-prostate-cancer
#17
David F Penson
No abstract text is available yet for this article.
January 2017: Journal of Urology
https://www.readbyqxmd.com/read/27967297/active-surveillance-as-a-therapeutic-option-for-patients-with-low-risk-prostate-cancer-according-to-the-2014-international-society-of-urological-pathology-grading-system-a-review
#18
Burkhard Helpap, Heidrun Gevensleben
Extended prostate-specific antigen screening and the tightly focused execution of biopsies have resulted in an increased rate of detection, and thereby increased interventional treatment, of prostate cancer (PCa). The potential overdiagnosis and overtreatment of PCa patients have repeatedly been criticized in national and international literature. Controlled monitoring of patients in the setting of active surveillance (AS) can prevent overtreatment and the needless impairment of quality of life. The prerequisite for this treatment strategy is the diagnosis of low-grade/risk PCa...
December 14, 2016: Scandinavian Journal of Urology
https://www.readbyqxmd.com/read/27965718/limiting-overdiagnosis-of-low-risk-prostate-cancer-through-an-evaluation-of-the-predictive-value-of-transrectal-and-power-doppler-ultrasonography
#19
Jean Luc Sauvain, Elise Sauvain, Roger Papavero, Didier Louis, Paul Rohmer
PURPOSE: Overdiagnosis induced by prostate cancer screening makes necessary a better selection of candidate patients for prostate biopsy. The objective of our study is to assess the probability of having a high- or low-risk lesion that could require active surveillance (AS) after biopsies and a normal or abnormal examination, including transrectal and power Doppler ultrasonography (TRUS-PDS). METHODS: Four hundred and twenty-nine consecutive patients with a PSA level <10 ng/ml and a normal digital rectal examination (DRE) had guided biopsies in a prospective study...
December 2016: Journal of Ultrasound
https://www.readbyqxmd.com/read/27923674/impact-of-a-decision-aid-on-newly-diagnosed-prostate-cancer-patients-understanding-of-the-rationale-for-active-surveillance
#20
Margaret K Formica, Shaun Wason, John D Seigne, Telisa M Stewart
OBJECTIVE: To compare newly diagnosed localized prostate cancer patients who did and did not view a decision aid (DA) on their knowledge of the rationale for active surveillance (AS). METHODS: A cross-sectional study was conducted among 452 newly diagnosed low-risk localized prostate cancer patients. Patients were mailed the video/DVD DA and completed a web-based questionnaire that contained two multiple choice questions assessing knowledge of the rationale for AS...
November 22, 2016: Patient Education and Counseling
keyword
keyword
109735
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"